Table 2 |
||||
| Survival data of 59 patients stratified into 3 risk groups according to baseline CTC counts | ||||
| Risk Group | Death N (%) | Censored N (%) | Quartile Survival [weeks] | Median Survival [weeks] |
| CTC-L (0 CTC) N = 20 | 2 (10.0) | 18 (90.0) | 100 95%CI = [85,+oo] | >100 95%CI = [85,+oo] |
| CTC-M (1-4 CTC) N = 15 | 7 (46.7) | 8 (53.3) | 32 95%CI = [12,78] | >78 95%CI = [20,+oo] |
| CTC-H (≥5 CTC) N = 24 | 17 (70.8) | 7 (29.2) | 22 95%CI = [2,42] | 60 95%CI = [27,73] |
| TOTAL N = 59 | 26 (44.1) | 33 (55.9) | 46 95%CI = [20,70] | 100 95%CI = [70,+oo] |
Quartile and median survival times are given together with confidence intervals (CI). N is the number of patients in the respective group.
Weissenstein et al. BMC Cancer 2012 12:206 doi:10.1186/1471-2407-12-206
